Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 3/20 | 0.40 |
| ▸ | CES1 | P23141 | 3/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 6/20 | 0.40 |
| ▸ | CNR1 | P21554 | 2/20 | 0.40 |
| ▸ | CNR2 | P34972 | 2/20 | 0.40 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 4/20 | 0.39 |
| ▸ | PPARD | Q03181 | 4/20 | 0.39 |
| ▸ | PPARA | Q07869 | 4/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.39 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.39 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.39 |
| ▸ | TLR2 | O60603 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18650257 | 0.91 | ALOX5 (0.62) | ALOX5TSHRALDH1A1CES2CES1 | |
| SCHEMBL12169161 | 0.90 | ALOX5 (0.81) | ALOX5TSHRALDH1A1PPARGPPARD | |
| SCHEMBL14438147 | 0.85 | ALOX5 (0.46) | ALOX5TSHRALDH1A1PAOXCES2 | |
| SCHEMBL8920945 | 0.85 | ALOX5 (0.86) | ALOX5TSHRALDH1A1PPARGPPARD | |
| SCHEMBL8920949 | 0.85 | ALOX5 (0.86) | ALOX5TSHRALDH1A1PPARGPPARD | |
| SCHEMBL25802613 | 0.83 | ALOX5 (0.53) | ALOX5TSHRALDH1A1PAOXTRPV1 | |
| SCHEMBL23390585 | 0.82 | ALOX5 (0.70) | ALOX5TSHRALDH1A1CES2CES1 | |
| SCHEMBL21173235 | 0.82 | ALOX5 (0.51) | ALOX5TRPV1CNR1CNR2PPARG | |
| SCHEMBL825822 | 0.81 | ALOX5 (0.93) | ALOX5TSHRALDH1A1PPARGPPARD | |
| SCHEMBL12169162 | 0.81 | ALOX5 (0.93) | ALOX5TSHRALDH1A1PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180042229-A1 | DEUTERIUM-ENRICHED ALDEHYDES | DEUTERIA AGROCHEMICALS, LLC | 2018-02-15 | — | — | US | disclosed |
| US-9713330-B1 | Deuterium-enriched aldehydes | DEUTERIA AGROCHEMICALS, LLC (US) | 2017-07-25 | — | — | US | disclosed |
| US-9179670-B2 | Deuterium-enriched aldehydes | DEUTERIA AGROCHEMICALS, LLC (US) | 2015-11-10 | — | — | US | disclosed |
| US-20150208651-A1 | DEUTERIUM-ENRICHED ALDEHYDES | DEUTERIA AGROCHEMICALS, LLC | 2015-07-30 | — | — | US | disclosed |
| US-9023336-B2 | Deuterium-enriched aldehydes | Deuterra Agrochemicals, LLC (US) | 2015-05-05 | — | — | US | disclosed |
| US-20140271537-A1 | DEUTERIUM-ENRICHED ALDEHYDES | DEUTERIA AGROCHEMICALS, LLC | 2014-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150208651-A1 | DEUTERIUM-ENRICHED ALDEHYDES | XDH, ALDH5A1, AOX1 | ALOX5 340/4885TSHR 2434/4885ALDH1A1 11/4885 |
| US-20140271537-A1 | DEUTERIUM-ENRICHED ALDEHYDES | XDH, ALDH5A1, AOX1 | ALOX5 340/4885TSHR 2434/4885ALDH1A1 11/4885 |
| US-20180042229-A1 | DEUTERIUM-ENRICHED ALDEHYDES | XDH, ALDH5A1, AOX1 | ALOX5 340/4885TSHR 2434/4885ALDH1A1 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.